Walking through the halls of the St. Francis Westin Hotel during the J.P. Morgan Global Health Conference, one can’t help but notice the growing presence of East Asians. Yet, when it comes to the highest levels of leadership, their representation remains disproportionately low.
Despite making up 25% of the pharmaceutical workforce in the US, East Asians occupy only 3% of C-Suite roles and hold a mere 1.2% of board seats, according to a...